Vincent Aurentz
Director/Board Member chez LONGBOARD PHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2024
Profil
Vincent E.
Aurentz is currently the Chairman at DoveTail Integrated Systems, Inc. and the Director at Longboard Pharmaceuticals, Inc. He previously worked as the President & Director at HemoShear Therapeutics, Inc., Executive Vice President at Quintiles Transnational Corp.
and Merck KGaA, Chief Business Officer & Executive Vice President at Arena Pharmaceuticals, Inc., and Chief Commercial Officer at Merck Serono SA. He also worked as a Partner at Computer Sciences Corp., Csc Healthcare Systems, Inc., and IQVIA Clinical AB, and as a Principal at Catenion GmbH.
Mr. Aurentz received his undergraduate degree from Villanova University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Vincent Aurentz
| Sociétés | Poste | Début |
|---|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Director/Board Member | 01/02/2020 |
DoveTail Integrated Systems, Inc.
 DoveTail Integrated Systems, Inc. BiotechnologyHealth Technology DoveTail Integrated Systems, Inc. develops platform solutions to deliver pre-engineered, pre-fabricated, pre-qualified manufacturing facilities suitable for a bio-pharmaceutical production processes including therapeutic proteins, vaccine, and fill finish configurations. The firm’s products include PlantConnex System and BioTypeKit. The company was founded by Bart van Praag and Gregg J. Pacchiana in 2010 and is headquartered in Hillsborough, NC. | Chairman | - |
Anciens postes connus de Vincent Aurentz
| Sociétés | Poste | Fin |
|---|---|---|
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01/03/2022 |
| EPIRUS BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2016 |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | President | 01/11/2015 |
| Catenion GmbH | Corporate Officer/Principal | 01/12/2014 |
IQVIA Clinical AB
 IQVIA Clinical AB Pharmaceuticals: MajorHealth Technology IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden. | Corporate Officer/Principal | 01/04/2012 |
Formation de Vincent Aurentz
| Villanova University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MERCK KGAA | Health Technology |
| EPIRUS BIOPHARMACEUTICALS, INC. | Health Technology |
| LONGBOARD PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Computer Sciences Corp.
 Computer Sciences Corp. Information Technology ServicesTechnology Services Computer Sciences Corp. provided information technology solutions. It operated through the global business services, global infrastructure services segments. The company was founded by Roy Nutt and Fletcher Roseberry Jones on April 16, 1959 and was headquartered in Tysons, VA. | Technology Services |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Health Services |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
| Csc Healthcare Systems, Inc. | |
IQVIA Clinical AB
IQVIA Clinical AB Pharmaceuticals: MajorHealth Technology IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden. | Health Technology |
DoveTail Integrated Systems, Inc.
DoveTail Integrated Systems, Inc. BiotechnologyHealth Technology DoveTail Integrated Systems, Inc. develops platform solutions to deliver pre-engineered, pre-fabricated, pre-qualified manufacturing facilities suitable for a bio-pharmaceutical production processes including therapeutic proteins, vaccine, and fill finish configurations. The firm’s products include PlantConnex System and BioTypeKit. The company was founded by Bart van Praag and Gregg J. Pacchiana in 2010 and is headquartered in Hillsborough, NC. | Health Technology |
| Catenion GmbH |
